Status and phase
Conditions
Treatments
About
This trial is to assess the efficacy and feasibility of consolidation chemotherapy after neoadjuvant chemoradiotherapy for locally advanced mid or low rectal cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Histologically confirmed adenocarcinoma of mid or low rectum
Locally advanced rectal cancer confirmed by image (i.e. Magnetic resonance image)
ECOG performance status of 0-2
ASA grade ≤ 3
An informed consent has been signed by the patient
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
358 participants in 2 patient groups
Loading...
Central trial contact
Suk-Hwan Lee, MD, PhD; Chang Woo Kim, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal